MG
CME icon

Mather Group’s CME Group CME Stock Holding History

Mather Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$759K Buy
2,570
+37
+1% +$11K 0.01% 388
2025
Q4 		$692K Buy
2,533
+320
+14% +$87K 0.01% 344
2025
Q3 		$598K Buy
2,213
+293
+15% +$79.7K 0.01% 371
2025
Q2 		$529K Buy
1,920
+47
+3% +$12.8K 0.01% 380
2025
Q1 		$497K Buy
1,873
+434
+30% +$107K 0.01% 378
2024
Q4 		$334K Buy
1,439
+49
+4% +$11.3K ﹤0.01% 447
2024
Q3 		$307K Sell
1,390
-4,676
-77% -$968K ﹤0.01% 460
2024
Q2 		$1.31M Buy
6,066
+4,025
+197% +$832K 0.02% 230
2024
Q1 		$430K Sell
2,041
-5,128
-72% -$1.08M 0.01% 368
2023
Q4 		$1.51M Sell
7,169
-130
-2% -$27.7K 0.02% 179
2023
Q3 		$1.46M Buy
7,299
+388
+6% +$77.1K 0.03% 169
2023
Q2 		$1.28M Buy
6,911
+145
+2% +$26.8K 0.02% 193
2023
Q1 		$1.3M Buy
+6,766
New +$1.22M 0.02% 185
2022
Q2 		– Sell
-898
Closed -$214K – 395
2022
Q1 		$214K Sell
898
-38
-4% -$8.92K ﹤0.01% 415
2021
Q4 		$214K Buy
+936
New +$206K ﹤0.01% 370

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mather Group's CME Position: Q1 2026 in Review

Mather Group increased its CME Group (CME) stake by 1.5% in Q1 2026, buying an estimated $11K and bringing the position to 2,570 shares worth $759K. The position accounts for 0.01% of the portfolio, ranked #388.

Mather Group first reported a position in CME in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.51M in Q4 2023. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Mather Group held 2,570 shares of CME Group worth $759K as of Q1 2026.
  • Mather Group bought 37 CME Group shares in Q1 2026, an estimated $11K.
  • CME Group made up 0.01% of Mather Group's portfolio in Q1 2026, its #388 holding.
  • Mather Group first reported a position in CME Group in Q4 2021 and has held it in 15 quarters since.
  • Mather Group's CME Group position peaked at $1.51M in Q4 2023.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.